Thomas W Chalberg

Avalanche Biotechnologies, Inc.

$3,275,591

Attributed

$5,560,358

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2012–22

$2M$1.5M$1M$500K$0

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$5,560,358 · 3

By mechanism

R44$5,300,439 · 2

R43$259,919 · 1

Top collaborators

Stephen J Smith8 shared

Others in their field

Top investigators on “Vision”

Chanza Baytop · Westat, Inc.$271,217,917
Edward W Maly · United Nations Children'S Fund$264,005,699
Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
Valerie Koch · University Corporation For Atmospheric Res$243,972,016
Everette D Joseph · Howard University$243,972,016

Research focus

VisionIntravitreal InjectionClinical TrialsSafetyInjection Of Therapeutic AgentPainTechnologyToxic EffectPre-ClinicalPhase Iii Clinical TrialsMedicineProceduresOcular SurfaceOryctolagus CuniculusCommercializationPatient SafetyFda ApprovedFormulationDiabeticCorneal EpitheliumBaseMacular EdemaPharmaceutical PreparationsResearch Clinical Testing